We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Maintaining that pricing pressure will continue in the US market, Dr Reddy’s Laboratories has said the company plans to launch several value-added products this fiscal to offset the persisting problem.